Anti-RNA Polymerase Antibodies Heighten Cancer RiskAnti-RNA Polymerase Antibodies Heighten Cancer Risk

Synchronous cancers are more common in patients with systemic sclerosis who have anti-RNA antibodies, so EUSTAR investigators recommend screening these patients. Medscape Medical News
Source: Medscape Pathology Headlines - Category: Pathology Tags: Rheumatology News Source Type: news